Antidiabetic Rosiglitazone Reduces Soluble Intercellular Adhesion Molecule-1 Level in Type 2 Diabetic Patients with Coronary Artery Disease

Background. We investigated the level of soluble adhesion molecules in diabetic patients and the effect of the peroxisome proliferator-activated receptor-γ (PPAR-γ) agonist rosiglitazone on plasma levels of adhesion molecules and an inflammation marker in type 2 diabetic patients with coronary arter...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Guang, Zhang, Zhe, Yu, Jie, Zhang, Fuchun, He, Liyun, Wei, Jinru, Mao, Jieming, Wang, Xian
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2008
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2605848/
https://www.ncbi.nlm.nih.gov/pubmed/19107216
http://dx.doi.org/10.1155/2008/548178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2605848/
https://www.ncbi.nlm.nih.gov/pubmed/19107216
http://dx.doi.org/10.1155/2008/548178

Ejemplares similares